Abstract
Plexiform lesions (PLs), which are often accompanied by perivascular infiltrates of mononuclear cells, represent the hallmark lesions of pulmonary arteries in humans suffering from severe pulmonary arterial hypertension (PAH). Endothelial progenitor cells (EPCs) have been recently implicated in the formation of PLs in human patients. PLs rarely develop in rodent animal models of PAH but can develop spontaneously in broiler chickens. The aim of the present study was to confirm the presence of EPCs in the PLs in broilers. The immune mechanisms involved in EPC dysfunction were also evaluated. Lungs were collected from commercial broilers at 1 to 4 weeks of age. The right/total ventricle ratios indicated normal pulmonary arterial pressures for all sampled birds. Immunohistochemistry was performed to determine the expressions of EPC markers (CD133 and VEGFR-2) and proangiogenic molecule hepatocyte growth factor (HGF) in the lung samples. An EPC/lymphocyte co-culture system was used to investigate the functional changes of EPCs under the challenge of immune cells. PLs with different cellular composition were detected in the lungs of broilers regardless of age, and they were commonly surrounded by moderate to dense perivascular mononuclear cell infiltrates. Immunohistochemical analyses revealed the presence of CD133+ and VEGFR-2+ cells in PLs. These structures also exhibited a strong expression of HGF. Lymphocyte co-culture enhanced EPC apoptosis and completely blocked HGF-stimulated EPC survival and in vitro tube formation. Taken together, this work provides evidence for the involvement of EPCs in the development of PLs in broilers. It is suggested that the local immune cell infiltrate might serve as a contributor to EPC dysfunction by inducing EPC death and limiting their response to angiogenic stimuli. Broiler chickens may be valuable for investigating reversibility of plexogenic arteriopathy using gene-modified inflammation-resistant EPCs.
Keywords: Plexiform lesions; Endothelial progenitor cells; Immune response; Hepatocyte growth factor; Broiler chicken
1. Introduction
Plexiform lesions (PLs), which are typically located at branching points of small pulmonary arteries and cause vascular lumen obliteration, represent the hallmark of severe pulmonary arterial hypertension (PAH) in humans, whether idiopathic or secondary (Jonigk et al., 2011; Bockmeyer et al., 2012), and are thought to signify a poor prognosis of PAH (Palevsky et al., 1989). A recent study by Lu et al. (2016) demonstrates that severe PAH is present in around 2% of patients suffering from heart diseases. It has long been considered that disordered endothelial cell proliferation gives rise to PLs (Masri et al., 2007; Sakao et al., 2009; Huang et al., 2010), but this remains a subject of debate because mature endothelial cells are indeed terminally differentiated with very low proliferative potential.
Recently, the role of progenitor cells in PAH-associated pulmonary vascular remodeling has been a focus of research (Yeager et al., 2011; Schiavon et al., 2012; Dierick et al., 2016). Endothelial progenitor cells (EPCs) are a population of angioblasts which are commonly defined by the co-expression of markers of bone marrow origin such as CD34 or CD133 in addition to the endothelial marker VEGFR-2 (also known as KDR or Flk-1) (Timmermans et al., 2009). Increasing evidence suggests that these cells play a fundamental role in tissue regeneration and vascular repair both by differentiating into mature endothelial cells and by secretion of proangiogenic mediators (George et al., 2011; Zhang et al., 2013). Interestingly, it has been found that PAH patients had increased EPCs (CD133+) in remodeled pulmonary arteries, specifically in PLs, leading to the suggestion that the formation of PLs is associated with EPC dysfunction (Toshner et al., 2009). However, the mechanisms underlying EPC dysfunction during the development of PLs remain poorly understood.
Multiple angiogenic molecules have been identified in PLs. Some of these molecules, e.g. vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) (Tuder et al., 2001; Jonigk et al., 2011), have indeed been repeatedly demonstrated to enhance EPC-dependent vascular repair in various animal models (Sanada et al., 2009; Song et al., 2009; Yu et al., 2010; 2014). In particular, HGF has been found to play a critical role in the angiogenic process in experimentally induced lung injury (Ishizawa et al., 2004). Given that the increased expressions of angiogenic molecules (e.g. HGF) in diseased vessels represent a counter-system against endothelial dysfunction (Morishita et al., 1998), some other factors contributing to the formation of PLs might have a detrimental effect on EPC-dependent angiogenesis. It is known that the formation of PLs is usually accompanied by a moderate to intense mononuclear infiltrate present around or within the affected arteries (Tuder et al., 1994; Cool et al., 1997). Therefore, the local immune/inflammatory environment might be involved in this process. However, the experimental evidence supportive of the hypothesis still needs to be established.
Plexogenic arteriopathy rarely develops in existing experimental animals (Firth et al., 2010; Colvin and Yeager, 2014), but can develop spontaneously in broiler chickens. Previous studies showed that PLs in broilers had histological and molecular features closely resembling human PLs (Wideman and Hamal, 2011; Wideman et al., 2011; Hamal et al., 2012), rendering the broilers particularly suitable for studying the molecular and cellular basis of the formation of PLs. The present work was conducted to confirm the presence of EPCs in the PLs in this avian model. We also examined the effect of lymphocyte co-culture on the function of EPCs, with an attempt to understand whether immune cell infiltrate contributes to the formation of PLs by impairing the angiogenic activity of EPCs.
2. Materials and methods
2.1. Lung tissue preparation
Sixty one-day-old broiler chickens (Cobb 500) were purchased from a commercial hatchery and reared under normoxic and thermoneutral conditions. The birds were fed a commercial maize-soybean pelleted feed formulated to meet or exceed minimum National Research Council (NRC, 1994) standards for all ingredients (21% crude protein, 3100 kcal (1 kcal= 4.1868 kJ) metabolizable energy (ME)/kg). Feed and water were provided ad libitum. The lighting schedule remained at continuous lighting (24 h light:0 h dark) during the experiment. At 1, 2, 3, and 4 weeks of age, a minimum of 8 birds were randomly selected and killed by cervical dislocation. Hearts were dissected and weighed to calculate the right/total ventricular weight (RV/TV) ratios. Birds with RV/TV>0.299 were considered to suffer from PAH (Walton et al., 2001). The whole left lung was collected and cut in the transverse plane at the major rib indentations (costal sulci). One interrib division from the middle of each lung was fixed in 4% (0.04 g/ml) paraformaldehyde.
2.2. Histological and immunohistochemical staining
Lung tissues were embedded in paraffin and serially sectioned in the transverse plane at 5 μm thickness. One slide of each lung was stained with haematoxylin and eosin to ascertain the presence of PLs. The remaining sections were used for immunochemical staining of CD133, VEGFR-2, and HGF. Briefly, sections were deparaffinized and treated with 3% (v/v) hydrogen peroxide to block endogenous peroxidase activity. Heat-induced antigen retrieval was performed in Tris/ethylene diamine tetraacetic acid (EDTA) (pH 9.0) in a pressure cooker. After blocking with 5% (0.05 g/ml) bovine serum albumin, the slides were incubated with the following antibodies: polyclone rabbit anti-rat CD133 (1:50 (v/v), Bostar Biological Technology, China), VEGFR-2 (1:50 (v/v), Boster Biotechnology Technology, China), and HGF (1:50 (v/v), Bostar Biological Technology, China). The primary antibody detection was performed using a standard labeled streptavidin-biotinylated antibody method and visualized with 3,3'-diaminobenzidine tetrahydrochloride (DAB), followed by counterstaining with haematoxylin. Omitting primary antibodies served as negative controls.
2.3. Ex vivo expansion of EPCs from peripheral blood
Isolation and ex vivo expansion of EPCs were carried out as previously described (Bi et al., 2014; Shah et al., 2014). Whole blood was collected from clinically healthy broilers at 4 weeks of age. Mononuclear cell fraction was obtained by density gradient centrifugation on a Ficoll-Paque (Tianjin Haoyang Biological Manufacture Co., Ltd., China). Cells were seeded on rat tail type 1 collagen-coated 6-well plates at a density of 1×107 cells/well, and cultured in Endothelial cell growth medium (EGM)-2 (Lonza, Walkersvil, MD, USA) containing 2% (v/v) fetal bovine serum (FBS; Gibco, USA), 100 U/ml penicillin, and 100 μg/ml streptomycin . After 24 h, the nonadherent cells were removed and the attached cells were cultured further in fresh growth medium. The culture medium was replaced every 3 d. Cell morphology was constantly monitored using phase contrast microscopy.
On Day 7 after plating, cells were co-stained with Dil-labeled acetylated low-density lipoprotein (Dil-ac-LDL, Invitrogen, Carlsbad, CA, USA) and fluorescein isothiocyanate (FITC)-labeled ulex europaeus agglutinin 1 (UEA-1) lectin (Sigma-Aldrich, St. Louis, MO, USA) as previously described (Bi et al., 2014; Shah et al., 2014). Cells presenting double-positive fluorescence were considered to be EPCs. For the determination of the progenitor and endothelial markers, cells were labeled with a phycoerythrin (PE)-conjugated monoclonal antibody against mouse CD133 (eBioscience, San Diego, CA, USA), or an allophycocyanin (APC)-conjugated anti-human VEGFR-2 (Miltenyi Biotec, Germany), at 4 °C for 20 min. After two steps of washing, the cells were subjected to flow cytometry using a fluorescence-activated cell sorter (FACS) Calibur flow cytometry (Beckman Coulter, CA, USA).
2.4. EPC/lymphocyte co-culture system
Peripheral blood mononuclear cell fraction was prepared from 6-week-old healthy birds as described above. The cells were incubated in Dulbecco’s modified Eagle’s medium (Gibco) at 39 °C in 5% CO2 for 2 h to allow the monocytes to adhere to the bottom of the culture plates. The lymphocytes floating in the medium were pelleted by centrifugation at 400g for 10 min. The viable cells were counted and resuspended in DMEM.
EPCs were trypsinized and replated onto 24-well plates at 1×105 cells/well. Cells were allowed to adhere for 12 h and then co-cultured with lymphocytes in DMEM containing 2% (v/v) FBS with or without human recombinant HGF (20 ng/ml; Sino Biological Inc., Beijing, China) for 24 h at 39 °C in 5% CO2. Results from our preliminary studies showed that EPCs treated with 20 ng/ml HGF for 24 h had increased proliferation and enhanced in vitro tube formation (data not shown). The ratio of lymphocytes to EPCs in co-cultures was 1:1. This ratio was chosen because our in vivo findings showed that the number of infiltrating mononuclear cells around most of the PLs was almost equal to that of the putative EPCs.
2.5. Methyl thiazolyl tetrazolium assay
The viability of EPCs in the co-culture system was determined using the methyl thiazolyl tetrazolium (MTT) assay. In the EPC/lymphocyte co-culture system, EPCs were adherent to the bottom of the culture plates and the lymphocytes were suspended in the culture medium, ensuring the removal of lymphocytes by washing. Briefly, cells were washed with 0.1 mol/L phosphate buffered saline (PBS) to remove lymphocytes and cultured in 200 ml fresh DMEM containing 10 mg/ml MTT (Sigma-Aldrich) for a further 4 h. At the end of incubation, the supernatant was carefully removed and 200 µl dimethyl sulfoxide (DMSO) was added to each well to dissolve the formazan crystals for 15 min in the dark. The absorbance of the solubilized product at 570 nm (A 570) was measured. Cell densities were plotted as the mean A 570 value of five replicates.
2.6. Flow cytometric analysis of cell apoptosis
The EPC apoptosis in the co-culture system was assessed using an annexin V-FITC kit (Beyotime Institute of Biotechnology, Nanjing, China) following the manufacturer’s protocol. Briefly, EPCs were detached with 0.25% trypsin/EDTA (Gibco) and then re-suspended in 195 µl annexin V binding buffer. Cells were incubated with 5 µl of annexin V-FITC at room temperature for 10 min, followed by incubation with 10 µl propidium iodide (PI) in 190 µl annexin V-binding buffer on ice. Annexin V-FITC+/PI− and annexin V-FITC+/PI+ cells were considered as apoptotic cells and quantified by flow cytometry (FACScan, Beckman Coulter).
2.7. Tubular formation assay
Matrigel matrix (BD Biosciences, San Jose, CA, USA), which was used to promote the differentiation of EPCs into capillary tube-like structures, was added into 96-well plates and allowed to polymerize by incubating at 39 °C for 30 min. Following treatment, EPCs were plated onto the surface of the solidified gel at 1×104 cells/well and incubated at 39 °C for 4 h. Network formation was observed with a phase-contrast microscope (Nikon, Japan) and representative fields (×20 magnification) were photographed. The number of master segments formed by cells was automatically counted in five random fields per well using the angiogenesis macro for ImageJ (Version 1.50b, NIH, USA).
2.8. Statistical analyses
Data are presented as mean±standard error of the mean (SEM). Data were analyzed using SPSS software (Version 22, IBM Corp., Armonk, NY, USA). Comparisons were made using one-way analysis of variance (ANOVA) as appropriate. The observed significance levels were adjusted with the Bonferroni test for multiple comparisons. P<0.05 was considered statistically significant.
3. Results
3.1. Histological findings
The RV/TV ratios of all sampled birds were indicative of normal pulmonary arterial pressures, although the birds at 1-week-old had a higher mean RV/TV ratio than those at ages of 2, 3, and 4 weeks (Table 1). PLs with different cellular compositions, presumed to be at different stages of maturation or differentiation, were determined in the lungs of birds at all ages sampled. Representative photomicrographs of PLs are shown in Fig. 1. The “immature” lesions displayed the cluster of epithelia-like cells with hyperchromatic nuclei and scanty cytoplasm; no elastic tissue formed the wall of the plexogenic vessels (Fig. 1a). These lesions closely resembled the PLs in human PAH described by Tuder et al. (1994). There were frequent observations of lesions consisting of macrophage-like cells (Fig. 1b). During the maturing process of the lesions, myofibroblasts and connective tissue matrix appeared and the macrophages became foam-like cells, with the formation of multiple slit-like vascular channels lined by flat and mildly atypical endothelial cells (Fig. 1c). More mature lesions exhibited a typical glomeruloid-like appearance, which had fewer cellular components in the matrix with multiple foam-like cells aligning around the periphery of the main body (Figs. 1d and 1e). Moderate to dense mononuclear cell infiltrates were often found around the affected arterioles (Figs. 1d and 1e). Lesions with multinucleated giant cell response were also identified (Fig. 1f); this type of plexogenic pulmonary arteriopathy was occasionally identified in human PAH (Heath and Smith, 1982).
Table 1.
Right/total ventricle weight ratios of broilers at 1 to 4 weeks of age
| Week | Number | RV/TV ratio |
|||
| Mean | SE | Median | Range | ||
| 1 | 9 | 0.216a | 0.08 | 0.209 | 0.183‒0.251 |
| 2 | 8 | 0.183b | 0.04 | 0.182 | 0.169‒0.200 |
| 3 | 11 | 0.171b | 0.04 | 0.169 | 0.148‒0.194 |
| 4 | 10 | 0.186b | 0.06 | 0.183 | 0.154‒0.220 |
Mean values of right/total ventricle weight (RV/TV) ratio were analyzed using the one-way ANOVA procedure. Different superscript letters indicate significant difference (P<0.01). SE: standard error
Fig. 1.
Representative images showing plexiform lesions (PLs) in the lungs
It is noted that we examined the lung sections from 1-to 4-week-old broilers and that the maturing process of PLs was not related to the ages. (a) Photomicrographs of a lesion in the lung of a 1-week-old broiler photographed in the same section at 200× (left panel) and 400× (right panel) magnifications. Note the epithelial-like cells in the body of the lesion. (b) A PL in the lung of a 1-week-old broiler. The lesion contains mainly macrophage-like cells (Mɸ). (c) A view of a small pulmonary arteriole in the lung of a 2-week-old broiler completely occluded by the complex lesion, showing foam-like macrophages (Mɸ), myofibroblasts (arrow), and spindle-like cells (arrowhead) embedded in the matrix. Multiple slit-like vascular channels (C) are found in the body. (d, e) More mature glomeruloid-like PLs in the lung of a 4-week-old broiler. These “mature” lesions are indicated by the multiple vascular channels (C) and foam-like cells (Mɸ) aligning around the periphery of the main body. The perivascular connective tissue displays mononuclear cell infiltrate (arrow). (f) A cross-sectional view of a lesion containing multinucleated giant cell (arrow) in a bird at 3 weeks of age. Scale bar=50 μm
3.2. Expressions of CD133, VEGFR-2, and HGF in PLs
We observed widespread vascular endothelial expression of CD133 in normal arterioles (Fig. 2a). On adjacent sections, these vessels were found also to express VEGFR-2 (Fig. 2b). Of particular note was the strong immunoreactivity of epithelial-like cells with CD133 (Fig. 2d) and VEGFR-2 (Fig. 2e) within the immature PLs, indicating a progenitor phenotype. In the glomeruloid-like PLs, the foam-like macrophages also showed strong expression in CD133 (Fig. 2g) and VEGFR-2 (Fig. 2h). HGF was also determined in normal vessels and PLs (Figs. 2c, 2f, and 2i).
Fig. 2.
Representative photomicrographs of immunohistochemical staining
Adjacent sections of lung tissues showing the expressions of CD133, VEGFR-2 as well as HGF in a normal pulmonary arteriole (a‒c), an immature plexiform lesion (PL) (d‒f), and a mature lesion (g‒i). The lung sections presented here are from 2-week-old broilers. Mɸ: foam-like macrophage. Scale bar=25 μm
3.3. Characterization of cultured EPCs
On Day 7 of plating, peripheral mononuclear cells displayed typical EPC characteristics such as spindle-shaped appearance (early EPCs) (Fig. 3a), Dil-ac-LDL/UEA-1-lectin double-positive (Fig. 3c), and the expressions of CD133 and VEGFR-2 (Fig. 3d). Nearly 97% of the cells were Dil-ac-LDL/lectin dual-positive. These cells grew and differentiated into cobblestone-like late EPCs around Day 14 after plating (Fig. 3b) and were used for experiments.
Fig. 3.
Characterization of endothelial progenitor cells (EPCs)
EPCs displayed a spindle-shape appearance on Day 7 of plating (a) and differentiated into monolayer of cobblestone-like cells on Day 14 (b). The ability of EPCs for DiL-ac-LDL uptake (red color) and the binding of FITC-UEA-1 lectin (green color) are shown in (c), while cells carrying both characteristics appear in orange. (d) Expressions of CD133 and VEGFR-2 were assessed by flow cytometry (gray line indicates the isotype control; black line indicates the antibody staining). Representative results are shown. Scale bar=100 μm (Note: for interpretation of the references to color in this figure legend, the reader is referred to the web version of this article)
3.4. Effect of lymphocyte challenge on EPC function in the presence or absence of HGF
Lymphocyte exposure did not alter the proliferative capacity of EPCs stimulated either with or without HGF (Fig. 4). Nevertheless, EPCs showed increased apoptosis in the presence of lymphocytes and the pro-survival effect of HGF on EPCs was completely inhibited by the lymphocyte challenge (Fig. 5).
Fig. 4.

Proliferation of endothelial progenitor cells (EPCs) determined by MTT assay at 570 nm
Cells were exposed to lymphocytes in the presence or absence of hepatocyte growth factor (HGF) for 24 h. The values are expressed as mean±SEM of five replicates. * P<0.05 vs. control; ## P<0.01 vs. lymphocyte treatment alone
Fig. 5.
Apoptosis of endothelial progenitor cells (EPCs)
(a) Representative flow cytometric plots of cell apoptosis in different treatment groups. Cells were labeled with annexin-V and propidium iodide (PI). Cells in the annexin V-FITC+/PI− and annexin V-FITC+/PI+ populations were regarded as apoptotic cells. (b) Summarized data on the percentage of apoptotic EPCs (mean±SEM of three replicates) in each group. * P<0.05, ** P<0.01 vs. control; ### P<0.001
We next used a Matrigel model to assess the in vitro capacity of EPCs to form capillary-like structures after they were exposed to lymphocytes for 24 h. As shown in Fig. 6, the total number as well as the total length of the master segments formed by EPCs on Matrigel matrix surface was not affected by lymphocyte challenge. HGF stimulation augmented the ability of EPCs to form tube-like structures; however, this effect was significantly inhibited by lymphocyte challenge.
Fig. 6.
In vitro tube morphogenesis of endothelial progenitor cells (EPCs)
Cells were seeded on a Martrigel surface after treatment with lymphocytes in the presence or absence of hepatocyte growth factor (HGF). A chart bar shows the number of master segments (a) and the total length of master segments relative to control (b), respectively. The values are expressed as mean±SEM of three replicates. *** P<0.001 vs. control; ## P<0.01, ### P<0.001. (c) Representative images of segments formed by EPCs on Matrigel surface
4. Discussion
PLs in the lungs of broilers have been documented previously in both PAH-susceptible and PAH-resistant broiler lines (Hamal et al., 2012; Wideman et al., 2015). In line with these findings, the present study demonstrated the presence of PLs in the lungs of commercial broilers. PLs were constantly detected in birds with normal pulmonary arterial pressures, supporting the notion that the development of PLs does not require pre-existing pulmonary hypertension (Wideman et al., 2015). In addition to the typical glomeruloid-like lesions described in previous studies (Wideman et al., 2015), we detected PLs composed mainly of epithelial-like cells, which appeared remarkably similar to those from humans with PAH (Tuder et al., 1994). In particular, an unusual form of plexogenic arteriopathy in human PAH, i.e. lesions accompanied by multinucleated giant cell response (Heath and Smith, 1982), was also detected in our commercial birds. Taken together, findings reported here demonstrate that PLs developed in broilers share all the reported morphological features of PLs from human PAH, validating the broiler chickens as a particularly useful model of spontaneous plexogenic arteriopathy.
One of the major findings in this work is that the epithelial-like cells accumulated in the immature PLs exhibited an EPC phenotype (CD133+ and VEGFR-2+). This finding from our avian model provides the first supportive evidence for the claim that EPCs contribute to the formation of PLs in the human (Toshner et al., 2009). Interestingly, in mature PLs with glomeruloid-like appearance, the foam-like macrophages also expressed both CD133 and VEGFR-2. These results raise a possibility that there is an intrinsic relationship between the two morphologically different cell types in the PLs. Indeed, it has been reported that CD133+ progenitors can differentiate into both fibroblasts and monocytes/macrophages in inflamed tissue (Kania et al., 2009). Therefore, it is very likely that there is a process of EPC-to-macrophage transition during the maturing of PLs. In context, our results suggest that EPCs may contribute to the initiation and perpetuation of PLs in the lungs of broilers.
Numerous angiogenic molecules have been previously identified in PLs of broilers (Hamal et al., 2012). In the present study, we found a strong expression of HGF in PLs, consistent with the studies on human PAH (Farha et al., 2011). As an important factor responsible for vascular repair, HGF has been shown to enhance EPC function and improve EPC transplant efficiency in experimentally induced arterial injury (Song et al., 2009; Yu et al., 2015). Therefore, the strong expression of HGF in PLs might be explained as an unsuccessful attempt of this molecule to stimulate EPC-dependent vascular repair or angiogenisis.
Similar to the findings in previous studies (Hamal et al., 2012; Wideman et al., 2015), we determined constant mononuclear cell infiltrate around PLs, indicating a role of immune/inflammatory cells in the development of PLs in broilers. The initiation of the inflammatory response remains unclear but is presumably related to the formation of disturbed flow in branch points. Disturbed flow naturally occurs in branch points and may lead to endothelial damage and, thereby, local inflammation (Jongstra-Bilen et al., 2006). It has long been considered that immune/inflammatory response contributes to both the physiological and pathological angiogenic process (Naldini and Carraro, 2005). Given that an appropriate inflammatory response contributes to the normal angiogenic process, we posited that the formation of PLs may be associated with abnormal immune/inflammatory response that may lead to EPC dysfunction, either directly or indirectly. We therefore used a cell co-culture system consisting of EPCs and lymphocytes at a ratio of 1:1 to test our hypothesis. We believed that our co-culture system would be more realistic to mimic the in vivo events than stimulating the EPC with a single type of proinflammatory cytokine (Balestrieri et al., 2010; Zhao et al., 2012). The EPC population used in this work was composed of so-called “late” EPCs, which have proliferative capacity and are able to differentiate into mature endothelial cells (Hur et al., 2004). Our results showed that lymphocyte exposure alone led to enhanced EPC death; moreover, lymphocyte challenge completely blocked HGF-stimulated EPC survival and in vitro tube formation by EPCs. In context, our in vitro findings allow us to argue that the formation of PLs may be associated with increased EPC death and inadequate response of these cells to angiogenic stimulation under the challenge of immune cells.
Some limitations of our in vitro study must be taken into consideration for interrupting the in vivo events. We acknowledge that our EPC/lymphocyte co-culture system did not adequately model the PL microenvironment in terms of the composition of the infiltrating immune cells, the cell-cell interaction, and the local concentration of HGF. In addition, since we only evaluated the angiogenic response of EPCs to HGF stimulation under lymphocyte challenge, it is not possible to rule out the possibility that EPCs may respond adequately to other proangiogenic factors under the same conditions.
5. Conclusions
The present study provides evidence that EPCs are involved in the formation of PLs in broilers, supporting the findings in human PAH. Our results also suggest that the local immune cell infiltrate may contribute to the development of PLs by inducing EPC death and limiting their response to angiogenic stimuli. Given the therapeutic potential of EPCs in repairing vascular damage (Sukmawati and Tanaka, 2015), transplantation of gene-modified inflammation-resistant EPCs (Liu et al., 2010) may be beneficial for intervention of the formation of PLs. Further studies are warranted to test this hypothesis.
Footnotes
Project supported by the Zhejiang Provincial Natural Science Foundation of China (No. LR12C18001)
Compliance with ethics guidelines: Xun TAN, Fan-guo JUAN, and Ali Q. SHAH declare that they have no conflict of interest.
All institutional and national guidelines for the care and use of laboratory animals were followed.
References
- 1.Balestrieri ML, Giovane A, Milone L, et al. Modification of the detrimental effect of TNF-α on human endothelial progenitor cells by fasudil and Y27632. J Biochem Mol Toxicol. 2010;24(6):351–360. doi: 10.1002/jbt.20345. (Available from: http://dx.doi.org/10.1002/jbt.20345) [DOI] [PubMed] [Google Scholar]
- 2.Bi S, Tan X, Ali SQ, et al. Isolation and characterization of peripheral blood-derived endothelial progenitor cells from broiler chickens. Vet J. 2014;202(2):396–399. doi: 10.1016/j.tvjl.2014.08.017. (Available from: http://dx.doi.org/10.1016/j.tvjl.2014.08.017) [DOI] [PubMed] [Google Scholar]
- 3.Bockmeyer CL, Maegel L, Janciauskiene S, et al. Plexiform vasculopathy of severe pulmonary arterial hypertension and microRNA expression. J Heart Lung Transplant. 2012;31(7):764–772. doi: 10.1016/j.healun.2012.03.010. (Available from: http://dx.doi.org/10.1016/j.healun.2012.03.010) [DOI] [PubMed] [Google Scholar]
- 4.Colvin KL, Yeager ME. Animal models of pulmonary hypertension: matching disease mechanisms to etiology of the human disease. J Pulm Respir Med. 2014;4(4):198. doi: 10.4172/2161-105X.1000198. (Available from: http://dx.doi.org/10.4172/2161-105X.1000198) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Cool CD, Kennedy D, Voelkel NF, et al. Pathogenesis and evolution of plexiform lesions in pulmonary hypertension associated with scleroderma and human immunodeficiency virus infection. Hum Pathol. 1997;28(4):434–442. doi: 10.1016/s0046-8177(97)90032-0. (Available from: http://dx.doi.org/10.1016/S0046-8177(97)90032-0) [DOI] [PubMed] [Google Scholar]
- 6.Dierick F, Hery T, Hoareau-Coudert B, et al. Resident PW1+ progenitor cells participate in vascular remodeling during pulmonary arterial hypertension. Circ Res. 2016;118(5):822–833. doi: 10.1161/CIRCRESAHA.115.307035. (Available from: http://dx.doi.org/10.1161/CIRCRESAHA.115.307035) [DOI] [PubMed] [Google Scholar]
- 7.Farha S, Asosingh K, Xu W, et al. Hypoxia-inducible factors in human pulmonary arterial hypertension: a link to the intrinsic myeloid abnormalities. Blood. 2011;117(13):3485–3493. doi: 10.1182/blood-2010-09-306357. (Available from: http://dx.doi.org/10.1182/blood-2010-09-306357) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Firth AL, Mandel J, Yuan JX. Idiopathic pulmonary arterial hypertension. Dis Model Mech. 2010;3(5-6):268–273. doi: 10.1242/dmm.003616. (Available from: http://dx.doi.org/10.1242/dmm.003616) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.George AL, Bangalore-Prakash P, Rajoria S, et al. Endothelial progenitor cell biology in disease and tissue regeneration. J Hematol Oncol. 2011;4(1):24. doi: 10.1186/1756-8722-4-24. (Available from: http://dx.doi.org/10.1186/1756-8722-4-24) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Hamal KR, Erf GF, Anthony NB, et al. Immunohistochemical examination of plexiform-like complex vascular lesions in the lungs of broiler chickens selected for susceptibility to idiopathic pulmonary arterial hypertension. Avian Pathol. 2012;41(2):211–219. doi: 10.1080/03079457.2012.663077. (Available from: http://dx.doi.org/10.1080/03079457.2012.663077) [DOI] [PubMed] [Google Scholar]
- 11.Heath D, Smith P. Plexiform lesions with giant cells. Thorax. 1982;37(5):394–395. doi: 10.1136/thx.37.5.394. (Available from: http://dx.doi.org/10.1136/thx.37.5.394) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Huang J, Wolk JH, Gewitz MH, et al. Progressive endothelial cell damage in an inflammatory model of pulmonary hypertension. Exp Lung Res. 2010;36(1):57–66. doi: 10.3109/01902140903104793. (Available from: http://dx.doi.org/10.3109/01902140903104793) [DOI] [PubMed] [Google Scholar]
- 13.Hur J, Yoon CH, Kim HS, et al. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol. 2004;24(2):288–293. doi: 10.1161/01.ATV.0000114236.77009.06. (Available from: http://dx.doi.org/10.1161/01.ATV.0000114236.77009.06) [DOI] [PubMed] [Google Scholar]
- 14.Ishizawa K, Kubo H, Yamada M, et al. Hepatocyte growth factor induces angiogenesis in injured lungs through mobilizing endothelial progenitor cells. Biochem Biophys Res Commun. 2004;324(1):276–280. doi: 10.1016/j.bbrc.2004.09.049. (Available from: http://dx.doi.org/10.1016/j.bbrc.2004.09.049) [DOI] [PubMed] [Google Scholar]
- 15.Jongstra-Bilen J, Haidari M, Zhu SN, et al. Low-grade chronic inflammation in regions of the normal mouse arterial intima predisposed to atherosclerosis. J Exp Med. 2006;203(9):2073–2083. doi: 10.1084/jem.20060245. (Available from: http://dx.doi.org/10.1084/jem.20060245) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Jonigk D, Golpon H, Bockmeyer CL, et al. Plexiform lesions in pulmonary arterial hypertension composition, architecture, and microenvironment. Am J Pathol. 2011;179(1):167–179. doi: 10.1016/j.ajpath.2011.03.040. (Available from: http://dx.doi.org/10.1016/j.ajpath.2011.03.040) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Kania G, Blyszczuk P, Stein S, et al. Heart-infiltrating prominin-1+/CD133+ progenitor cells represent the cellular source of transforming growth factor β-mediated cardiac fibrosis in experimental autoimmune myocarditis. Circ Res. 2009;105(5):462–470. doi: 10.1161/CIRCRESAHA.109.196287. (Available from: http://dx.doi.org/10.1161/CIRCRESAHA.109.196287) [DOI] [PubMed] [Google Scholar]
- 18.Liu JW, Dunoyer-Geindre S, Blot-Chabaud M, et al. Generation of human inflammation-resistant endothelial progenitor cells by A20 gene transfer. J Vasc Res. 2010;47(2):157–167. doi: 10.1159/000250094. (Available from: http://dx.doi.org/10.1159/000250094) [DOI] [PubMed] [Google Scholar]
- 19.Lu H, Pan WZ, Wan Q, et al. Trends in the prevalence of heart diseases over a ten-year period from single-center observations based on a large echocardiographic database. J Zhejiang Univ-Sci B (Biomed & Biotechnol) 2016;17(1):54–59. doi: 10.1631/jzus.B1500136. (Available from: http://dx.doi.org/10.1631/jzus.B1500136) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Masri FA, Xu W, Comhair SA, et al. Hyperproliferative apoptosis-resistant endothelial cells in idiopathic pulmonary arterial hypertension. Am J Physiol Lung Cell Mol Physiol. 2007;293(3):L548–L554. doi: 10.1152/ajplung.00428.2006. (Available from: http://dx.doi.org/10.1152/ajplung.00428.2006) [DOI] [PubMed] [Google Scholar]
- 21.Morishita R, Nakamura S, Hayashi S, et al. Contribution of a vascular modulator, hepatocyte growth factor (HGF), to the pathogenesis of cardiovascular disease. J Atheroscler Thromb. 1998;4(3):128–134. doi: 10.5551/jat1994.4.128. (Available from: http://dx.doi.org/10.5551/jat1994.4.128) [DOI] [PubMed] [Google Scholar]
- 22.Naldini A, Carraro F. Role of inflammatory mediators in angiogenesis. Curr Drug Targets Inflamm Allergy. 2005;4(1):3–8. doi: 10.2174/1568010053622830. (Available from: http://dx.doi.org/10.2174/1568010053622830) [DOI] [PubMed] [Google Scholar]
- 23.NRC (National Research Council) Nutrient Requirements of Poultry, 9th Ed. Washington, DC: National Academies Press; 1994. [Google Scholar]
- 24.Palevsky HI, Schloo BL, Pietra GG, et al. Primary pulmonary hypertension. Vascular structure, morphometry, and responsiveness to vasodilator agents. Circulation. 1989;80(5):1207–1221. doi: 10.1161/01.cir.80.5.1207. (Available from: http://dx.doi.org/10.1161/01.CIR.80.5.1207) [DOI] [PubMed] [Google Scholar]
- 25.Sakao S, Tatsumi K, Voelkel NF. Endothelial cells and pulmonary arterial hypertension: apoptosis, proliferation, interaction and transdifferentiation. Respir Res. 2009;10(1):95. doi: 10.1186/1465-9921-10-95. (Available from: http://dx.doi.org/10.1186/1465-9921-10-95) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Sanada F, Taniyama Y, Azuma J, et al. Hepatocyte growth factor, but not vascular endothelial growth factor, attenuates angiotensin II-induced endothelial progenitor cell senescence. Hypertension. 2009;53(1):77–82. doi: 10.1161/HYPERTENSIONAHA.108.120725. (Available from: http://dx.doi.org/10.1161/hypertensionaha.108.120725) [DOI] [PubMed] [Google Scholar]
- 27.Schiavon M, Fadini GP, Lunardi F, et al. Increased tissue endothelial progenitor cells in end-stage lung diseases with pulmonary hypertension. J Heart Lung Transplant. 2012;31(9):1025–1030. doi: 10.1016/j.healun.2012.06.005. (Available from: http://dx.doi.org/10.1016/j.healun.2012.06.005) [DOI] [PubMed] [Google Scholar]
- 28.Shah QA, Tan X, Bi S, et al. Differential characteristics and in vitro angiogenesis of bone marrow-and peripheral blood-derived endothelial progenitor cells: evidence from avian species. Cell Prolif. 2014;47(4):290–298. doi: 10.1111/cpr.12111. (Available from: http://dx.doi.org/10.1111/cpr.12111) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Song MB, Yu XJ, Zhu GX, et al. Transfection of HGF gene enhances endothelial progenitor cell (EPC) function and improves EPC transplant efficiency for balloon-induced arterial injury in hypercholesterolemic rats. Vascul Pharmacol. 2009;51(2-3):205–213. doi: 10.1016/j.vph.2009.06.009. (Available from: http://dx.doi.org/10.1016/j.vph.2009.06.009) [DOI] [PubMed] [Google Scholar]
- 30.Sukmawati D, Tanaka R. Introduction to next generation of endothelial progenitor cell therapy: a promise in vascular medicine. Am J Transl Res. 2015;7(3):411–421. [PMC free article] [PubMed] [Google Scholar]
- 31.Timmermans F, Plum J, Yoder MC, et al. Endothelial progenitor cells: identity defined? J Cell Mol Med. 2009;13(1):87–102. doi: 10.1111/j.1582-4934.2008.00598.x. (Available from: http://dx.doi.org/10.1111/j.1582-4934.2008.00598.x) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Toshner M, Voswinckel R, Southwood M, et al. Evidence of dysfunction of endothelial progenitors in pulmonary arterial hypertension. Am J Respir Crit Care Med. 2009;180(8):780–787. doi: 10.1164/rccm.200810-1662OC. (Available from: http://dx.doi.org/10.1164/rccm.200810-1662OC) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Tuder RM, Groves B, Badesch DB, et al. Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension. Am J Pathol. 1994;144(2):275–285. [PMC free article] [PubMed] [Google Scholar]
- 34.Tuder RM, Chacon M, Alger L, et al. Expression of angiogenesis-related molecules in plexiform lesions in severe pulmonary hypertension: evidence for a process of disordered angiogenesis. J Pathol. 2001;195(3):367–374. doi: 10.1002/path.953. (Available from: http://dx.doi.org/10.1002/path.953) [DOI] [PubMed] [Google Scholar]
- 35.Walton JP, Julian RJ, Squires EJ. The effects of dietary flax oil and antioxidants on ascites and pulmonary hypertension in broilers using a low temperature model. Br Poult Sci. 2001;42(1):123–129. (Available from: http://dx.doi.org/10.1080/00071660020035190) [PubMed] [Google Scholar]
- 36.Wideman RF, Hamal KR, Bayona MT, et al. Plexiform lesions in the lungs of domestic fowl selected for susceptibility to pulmonary arterial hypertension: incidence and histology. Anat Rec (Hoboken) 2011;294(5):739–755. doi: 10.1002/ar.21369. (Available from: http://dx.doi.org/10.1002/ar.21369) [DOI] [PubMed] [Google Scholar]
- 37.Wideman RJ, Hamal KR. Idiopathic pulmonary arterial hypertension: an avian model for plexogenic arteriopathy and serotonergic vasoconstriction. J Pharmacol Toxicol Methods. 2011;63(3):283–295. doi: 10.1016/j.vascn.2011.01.002. (Available from: http://dx.doi.org/10.1016/j.vascn.2011.01.002) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Wideman RJ, Mason JG, Anthony NB, et al. Plexogenic arteriopathy in broiler lungs: evaluation of line, age, and sex influences. Poult Sci. 2015;94(4):628–638. doi: 10.3382/ps/pev018. (Available from: http://dx.doi.org/10.3382/ps/pev018) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Yeager ME, Frid MG, Stenmark KR. Progenitor cells in pulmonary vascular remodeling. Pulm Circ. 2011;1(1):3–16. doi: 10.4103/2045-8932.78095. (Available from: http://dx.doi.org/10.4103/2045-8932.78095) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Yu D, Chen W, Ren J, et al. VEGF-PKD1-HDAC7 signaling promotes endothelial progenitor cell migration and tube formation. Microvasc Res. 2014;91:66–72. doi: 10.1016/j.mvr.2013.10.006. (Available from: http://dx.doi.org/10.1016/j.mvr.2013.10.006) [DOI] [PubMed] [Google Scholar]
- 41.Yu F, Lin Y, Zhan T, et al. HGF expression induced by HIF-1α promote the proliferation and tube formation of endothelial progenitor cells. Cell Biol Int. 2015;39(3):310–317. doi: 10.1002/cbin.10397. (Available from: http://dx.doi.org/10.1002/cbin.10397) [DOI] [PubMed] [Google Scholar]
- 42.Yu X, Song M, Chen J, et al. Hepatocyte growth factor protects endothelial progenitor cell from damage of low-density lipoprotein cholesterol via the PI3K/Akt signaling pathway. Mol Biol Rep. 2010;37(5):2423–2429. doi: 10.1007/s11033-009-9753-6. (Available from: http://dx.doi.org/10.1007/s11033-009-9753-6) [DOI] [PubMed] [Google Scholar]
- 43.Zhang J, Zhang X, Li H, et al. Hyperglycaemia exerts deleterious effects on late endothelial progenitor cell secretion actions. Diab Vasc Dis Res. 2013;10(1):49–56. doi: 10.1177/1479164112444639. (Available from: http://dx.doi.org/10.1177/1479164112444639) [DOI] [PubMed] [Google Scholar]
- 44.Zhao J, Bolton EM, Ormiston ML, et al. Late outgrowth endothelial progenitor cells engineered for improved survival and maintenance of function in transplant-related injury. Transpl Int. 2012;25(2):229–241. doi: 10.1111/j.1432-2277.2011.01387.x. (Available from: http://dx.doi.org/10.1111/j.1432-2277.2011.01387.x) [DOI] [PubMed] [Google Scholar]





